Avoid Tamiflu at all costs as it is a useless, dangerous drug; the only pharmaceutical known to reduce the replication and viral load of this weaponised virus that was created at Kobe University Japan by Yoshihiro Kawaoka and Teridah Ernala Ginting is and continues to be Ribavirin
BBC
02/20/2015
Indian health officials are struggling to contain a swine flu outbreak that has killed more than 700 people since it took hold in mid-December.
 |
H1N1 |
The number of cases has doubled since last week to more than 11,000.
Critics have accused the government of failing to distribute medicines, but officials insisted the situation was under control.
This year's outbreak of the H1N1 virus, which causes swine flu, is the deadliest in India since 2010.
The virus first appeared in Mexico in 2009 and rapidly spread around the world.
The northern state of Rajasthan has been worst affected.
 |
NEVER listen to or heed CDC advisories |
Health authorities across India have launched TV and radio campaigns to tell people about precautions they can take to avoid the flu.
Health Minister JP Nadda attempted to rebuff reports of drug shortages.
"If any medicine store refuses to give medicines after showing a medical prescription, it should be reported to the authorities and action will be taken," he said.
He said there was no need to panic, and insisted the government was monitoring the situation closely.
 |
Kobe University virus weaponsers Teridah Ernala Ginting (second from left) and Yoshihiro Kawaoka (center) |
Experts investigating the cause of the outbreak say low winter temperatures are to blame.
This news bureau contains copyrighted material the use
of which has not always been specifically authorized by the copyright owner. We
are making such material available in our efforts to advance understanding of
environmental, political, human rights, economic, democracy, scientific, and
social justice issues, etc. We believe this constitutes a 'fair use' of
any such copyrighted material as provided for in section 107 of the US
Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on
this site is distributed without profit to those who have expressed a prior
interest in receiving the included information for research and educational
purposes.